Dabigatran versus warfarin in patients with atrial fibrillation - The New England Journal of Medicine - 2009
Brief Summary:
The RELY trial demonstrated that compared to warfarin, high dose dabigatran reduces stroke risk without increasing the risk of major bleeding among patients with atrial fibrillation.Reference: http://www.ncbi.nlm.nih.gov/pubmed/19717844
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you